Position in ROIV
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$306,442
+$96,777 QoQ
Shares Held
8,659
-10.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#321
of 494 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026POLEN CAPITAL MANAGEMENT LLC holds $29,188,603 across 18 Biotechnology names. ROIV ranks #17 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TSHA |
Taysha Gene Therapies, Inc.
|
489,219 | $3,331,581 | |
| 2 | SRRK |
Scholar Rock Holding Corp
|
52,132 | $2,867,260 | |
| 3 | DRTS |
Alpha Tau Medical Ltd.
|
220,751 | $2,777,047 | |
| 4 | PTGX |
Protagonist Therapeutics, Inc
|
22,651 | $2,776,559 | |
| 5 | MIRM |
Mirum Pharmaceuticals, Inc.
|
20,899 | $2,446,645 | |
| 6 | PRAX |
Praxis Precision Medicines, Inc.
|
7,252 | $2,427,897 | |
| 7 | AKTS |
Aktis Oncology, Inc.
|
63,514 | $2,047,056 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
24,916 | $2,032,398 |
All Filings in ROIV
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $306,442 | 8,659 | Shares | Sole | 2026-08-04 | |
| 2025-12-31 | $209,665 | 9,662 | Shares | Sole | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||